Dalbavancin activity tested against rarely isolated Gram-positive organism species from Europe

被引：0
|
作者：
Jones, R.
Sader, H.
Fritsche, T.
Stilwell, M.
机构：
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2007年 / 29卷
关键词：
D O I：
10.1016/S0924-8579(07)70623-4
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S195 / S196
页数：2
相关论文
共 50 条
  • [1] Dalbavancin Comparative Activity Tested Against Gram-positive Species in German Medical Centers: Results from the DECIDE Program
    Just-Nuebling, G.
    Falk, W.
    Schmitz, F. J.
    Rodloff, A.
    Biedenbach, D.
    Jones, R.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E259 - E260
  • [2] In vitro activity of dalbavancin against Gram-positive bacteria isolated from diabetic foot osteomyelitis
    Pantel, Alix
    Nachar, Oriane
    Boudet, Agathe
    Loubet, Paul
    Schuldiner, Sophie
    Cellier, Nicolas
    Sotto, Albert
    Dunyach-Remy, Catherine
    Lavigne, Jean-Philippe
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (08) : 2057 - 2060
  • [3] Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centres
    Sader, Helio S.
    Mendes, Rodrigo E.
    Pfaller, Michael A.
    Flamm, Robert K.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (05) : 1306 - 1310
  • [4] Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres
    Gales, AC
    Sader, HS
    Jones, RN
    CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (02) : 95 - 100
  • [5] Activity of dalbavancin against gram-positive cocci isolated from skin and soft tissue infections in Poland
    Stefaniuk, Elzbieta M.
    Dudek, Monika
    Hryniewicz, Waleria
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 95 (04)
  • [6] THE NATURE OF POLYMYXIN ACTIVITY AGAINST A GRAM-POSITIVE ORGANISM
    RHODES, RE
    VILA, OA
    FERLAUTO, RJ
    ANTIBIOTICS AND CHEMOTHERAPY, 1953, 3 (05) : 509 - 512
  • [7] Daptomycin activity when tested against uncommonly isolated streptococcal species and three other Gram-positive species groups
    Sader, H. S.
    Flamm, R. K.
    Jones, R. N.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S62 - S62
  • [8] Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004)
    Jones, RN
    Stilwell, MG
    Sader, HS
    Fritsche, TR
    Goldstein, BP
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 54 (02) : 149 - 153
  • [9] Dalbavancin Activity Tested Against a Contemporary Collection of Gram-positive Bacteria from Hospitals in the UK and Ireland: Results from DECIDE Program
    Cormican, M.
    Bowker, K.
    Howe, R.
    Smyth, E.
    Jones, R.
    Biedenbach, D.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E258 - E259
  • [10] Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive Infections
    Smith J.R.
    Roberts K.D.
    Rybak M.J.
    Infectious Diseases and Therapy, 2015, 4 (3) : 245 - 258
12345